Perioperative GFR Monitoring to Predict CSA-AKI and CA-AKI
Official title: Establishment and Validation of an Early Warning Model for Acute Kidney Injury During the Perioperative Period of Cardiovascular Diseases.
Run by China National Center for Cardiovascular Diseases · NCT07749417 · Data updated 2026-11-12
This study tests whether perioperative transcutaneous fluorescence GFR measurements can predict CSA-AKI or CA-AKI in adults undergoing cardiovascular procedures or iodine contrast exposure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 436 (estimated) |
| Sponsor | China National Center for Cardiovascular Diseases Government |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | July 17, 2026 |
| Main results expected | July 2029 |
| Study ends | July 2029 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT07749417 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) scheduled for elective cardiovascular surgery or contrast-enhanced imaging (CTA/PCI) and those with AKI risk who may develop CSA-AKI or CA-AKI.
✕Probably not a fit
Patients with advanced kidney disease requiring renal replacement therapy or those with AKI who do not recover prior to the exposure are less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects continuous perioperative GFR data using a fluorescence-based tracer to see if GFR trajectories can forecast CSA-AKI and CA-AKI before standard criteria are met. Participants are adults undergoing elective cardiovascular surgery, CTA, or PCI who receive the fluorescent tracer. Researchers compare GFR trajectories with subsequent AKI development and severity to identify early patterns. Data will include perioperative and peri-contrast hemodynamics and other clinical characteristics to contextualize the findings. The goal is to determine whether real-time kidney function monitoring can enable earlier recognition of AKI risk.
Why it matters
Potential benefit: If successful, this approach could allow earlier detection of AKI risk and timely interventions for patients undergoing cardiovascular procedures or contrast exposure.
How similar studies have gone: Prior studies in similar imaging-based kidney monitoring approaches have shown promise, but this specific perioperative fluorescence GFR trajectory method remains exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years old; 2. Specific inclusion criteria for the cohort: * GFR trajectory characterization after cardiovascular surgery or Iodine contrast agent exposure: Patients scheduled for elective cardiovascular surgery or interventional cardiovascular surgery or CTA; ② GFR trajectory characterization of AKI: Patients with confirmed CSA-AKI or contrast-associated acute kidney injury (CA-AKI). Exclusion Criteria: 1. Received renal replacement therapy before surgery or before contrast imaging, including kidney transplantation and regular dialysis; 2. Serum creatinine \> 353 μmol/L before surgery or before contrast imaging; 3. Patients with AKI who did not recover before surgery or before contrast imaging; 4. Patients with malignant tumors.
Where it's running
-
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Jianfang Cai
- Email: caijfbj@126.com
- Phone: +86 15801601007
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery
This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Biomarkers to predict CSA-AKI risk before heart surgery
This study tests new biomarkers to see if they can predict CSA-AKI risk in adults undergoing cardiovascular surgery.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
Restarting RAS inhibitors after AKI: a quick test in hospitalized adults
This pilot study tests whether restarting renin-angiotensin system inhibitors early after acute kidney injury is feasible and safe in hospitalized adults already using these medicines.
-
FST Decision Support to Help Timely Therapy for Kids with AKI Risk
This study tests whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe AKI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.